Healthcare - Drug Manufacturers - Specialty & Generic - NYSE - US
$ 8.47
-5.89 %
$ 3.91 B
Market Cap
-9.85
P/E
CASH FLOW STATEMENT
346 M
OPERATING CASH FLOW
-69.2 M
INVESTING CASH FLOW
-213 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Amneal Pharmaceuticals, Inc.
| Net Income | -48.7 M |
| Depreciation & Amortization | 229 M |
| Capital Expenditures | -69.2 M |
| Stock-Based Compensation | 26.8 M |
| Change in Working Capital | -47.2 M |
| Others | 232 M |
| Free Cash Flow | 276 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||
| Net Income | (48.7) | (254.8) | 20.2 | 68.6 | (603.6) | (201.3) | 169.3 | 209.4 | 169.5 | 176.9 |
| Depreciation & Amortization | 229.4 | 240.2 | 233.4 | 235.4 | 207.2 | 137.4 | 45.9 | 33.0 | 25.4 | 20.3 |
| Deferred Income Tax | 0 | 0 | 83.4 | 95.6 | 371.7 | (9.4) | 0.7 | 0.1 | 0 | 0 |
| Stock Based Compensation | 26.8 | 31.8 | 28.4 | 20.8 | 21.7 | 167.6 | 0 | 0 | 0 | 0 |
| Other Operating Activities | 185.3 | 107.8 | 10.0 | 20.0 | 124.9 | 149.0 | 14.5 | 3.3 | (90.0) | (85.0) |
| Change in Working Capital | (47.2) | (59.9) | (133.6) | (61.3) | (120.2) | 7.0 | (1.0) | (152.2) | (122.7) | (93.3) |
| Cash From Operations | 345.6 | 65.1 | 241.8 | 379.0 | 1.7 | 250.2 | 234.2 | 115.1 | 104.9 | 112.3 |
| INVESTING CASH FLOW | ||||||||||
| Capital Expenditures | (69.2) | (90.6) | (52.6) | (66.2) | (97.4) | (97.1) | (114.3) | (124.6) | (117.4) | (79.4) |
| Other Items | 0 | (83.7) | (141.5) | (251.4) | 77.9 | (299.3) | 15.7 | 0 | (18.2) | (41.6) |
| Cash From Investing Activities | (69.2) | (174.3) | (194.2) | (317.5) | (19.6) | (396.4) | (98.6) | (124.6) | (135.6) | (121.0) |
| FINANCING CASH FLOW | ||||||||||
| Common Stock Repurchased | (2.4) | (3.6) | (2.7) | (0.9) | (0.9) | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (196.3) | (123.3) | (78.2) | 143.0 | (29.3) | 541.0 | 286.1 | 188.6 | 187.0 | 298.5 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | (183.0) | (375.3) | (200.6) | (258.2) | (243.0) |
| Other Financing Activities | (13.8) | 20.2 | (57.3) | (11.2) | (16.6) | (70.4) | (5.9) | (7.5) | 46.2 | (7.4) |
| Cash From Financing Activities | (212.6) | (106.6) | (138.1) | 131.8 | (45.8) | 287.7 | (95.0) | (19.5) | (25.0) | 48.1 |
| CHANGE IN CASH | ||||||||||
| Net Change In Cash | 63.9 | (221.5) | (90.4) | 194.3 | (66.0) | 140.9 | 40.4 | (27.6) | (56.4) | 35.6 |
| FREE CASH FLOW | ||||||||||
| Free Cash Flow | 276.4 | (25.5) | 189.2 | 312.8 | (95.7) | 153.1 | 119.9 | (9.5) | (12.5) | 32.9 |